Wird geladen...
MET targeted therapy for lung cancer: clinical development and future directions
MET, the receptor for hepatocyte growth factor, has been identified as a novel promising target in various human malignancies, including lung cancer. Research studies have demonstrated that MET signaling plays important physiologic roles in embryogenesis and early development, whereas its deregulati...
Gespeichert in:
| Veröffentlicht in: | Lung Cancer (Auckl) |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312490/ https://ncbi.nlm.nih.gov/pubmed/28210125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S23423 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|